Taysha Gene Therapies, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINESCHEDULE 13G/ATaysha Gene Therapies, Inc.TSHAAug 14

   Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)

   RA CAPITAL MANAGEMENT, L.P., filed by

2. ROUTINESCHEDULE 13G/ATaysha Gene Therapies, Inc.TSHAAug 13

   Ownership stake disclosure by Stanley Morgan (amended)

   Stanley Morgan, filed by

3. NOTABLE10-QTaysha Gene Therapies, Inc.TSHAAug 11

   Quarterly report

4. ROUTINE8-KTaysha Gene Therapies, Inc.TSHAAug 11

   Current report

5. ROUTINE4Taysha Gene Therapies, Inc.TSHAJul 10

   Sukumar Nagendran, insider filing for TSHA

   Sukumar Nagendran, reporting

6. ROUTINE144Taysha Gene Therapies, Inc.TSHAJul 10

   Sukumar Nagendran, planned sale of TSHA shares

   Sukumar Nagendran, reporting

7. ROUTINE8-KTaysha Gene Therapies, Inc.TSHAJun 25

   Current report

8. ROUTINE424B5Taysha Gene Therapies, Inc.TSHAJun 25

   Securities offering

9. ROUTINE424B5Taysha Gene Therapies, Inc.TSHAJun 24

   Securities offering

10. ROUTINE8-KTaysha Gene Therapies, Inc.TSHAJun 22

    Current report

11. ROUTINE4Taysha Gene Therapies, Inc.TSHAJun 2

    4 insider filings

    Laura Sepp-Lorenzino, insider filing for TSHA

    Show all 4

    • 4Insider filing for TSHAJun 2
    • 4Insider filing for TSHAJun 2
    • 4Insider filing for TSHAJun 2
    • 4Insider filing for TSHAJun 2

    Laura Sepp-Lorenzino, reporting

12. ROUTINE8-KTaysha Gene Therapies, Inc.TSHAJun 2

    Current report

13. ROUTINESCHEDULE 13G/ATaysha Gene Therapies, Inc.TSHAMay 15

    Ownership stake disclosure by Vestal Point Capital, LP (amended)

    Vestal Point Capital, LP, filed by

14. ROUTINESCHEDULE 13G/ATaysha Gene Therapies, Inc.TSHAMay 15

    Ownership stake disclosure by RTW INVESTMENTS, LP (amended)

    RTW INVESTMENTS, LP, filed by

15. NOTABLE10-QTaysha Gene Therapies, Inc.TSHAMay 6

    Quarterly report

16. ROUTINE8-KTaysha Gene Therapies, Inc.TSHAMay 6

    Current report

17. ROUTINEARSTaysha Gene Therapies, Inc.TSHAApr 22

    Annual report to shareholders

18. ROUTINEDEFA14ATaysha Gene Therapies, Inc.TSHAApr 22

    Additional proxy materials

19. ROUTINEDEF 14ATaysha Gene Therapies, Inc.TSHAApr 22

    Proxy statement

20. ROUTINE4Taysha Gene Therapies, Inc.TSHAApr 13

    Sukumar Nagendran, insider filing for TSHA

    Sukumar Nagendran, reporting

21. ROUTINE144Taysha Gene Therapies, Inc.TSHAApr 10

    Sukumar Nagendran, planned sale of TSHA shares

    Sukumar Nagendran, reporting

22. NOTABLE10-KTaysha Gene Therapies, Inc.TSHAMar 19

    Annual report

23. ROUTINE8-KTaysha Gene Therapies, Inc.TSHAMar 19

    Current report

24. ROUTINE144Taysha Gene Therapies, Inc.TSHAFeb 27

    Rumana Haque-Ahmed, planned sale of TSHA shares

    Rumana Haque-Ahmed, reporting

25. ROUTINESCHEDULE 13GTaysha Gene Therapies, Inc.TSHAFeb 17

    Ownership stake disclosure by Vestal Point Capital, LP

    Vestal Point Capital, LP, filed by

26. ROUTINESCHEDULE 13G/ATaysha Gene Therapies, Inc.TSHAFeb 17

    Ownership stake disclosure by RTW INVESTMENTS, LP (amended)

    RTW INVESTMENTS, LP, filed by

27. ROUTINE4Taysha Gene Therapies, Inc.TSHAFeb 6

    Kamran Alam, insider filing for TSHA

    Kamran Alam, reporting

28. ROUTINESCHEDULE 13G/ATaysha Gene Therapies, Inc.TSHAFeb 5

    Ownership stake disclosure by FMR LLC (amended)

    FMR LLC, filed by

29. ROUTINE144Taysha Gene Therapies, Inc.TSHAFeb 4

    5 Form 144 notices

    Emily McGinnis, planned sale of TSHA shares

    Show all 5

    • 144Planned insider sale of TSHA sharesFeb 4
    • 144Planned insider sale of TSHA sharesFeb 4
    • 144Planned insider sale of TSHA sharesFeb 4
    • 144Planned insider sale of TSHA sharesFeb 4
    • 144Planned insider sale of TSHA sharesFeb 4

    Emily McGinnis, reporting

30. ROUTINE4Taysha Gene Therapies, Inc.TSHAJan 27

    3 insider filings

    Sukumar Nagendran, insider filing for TSHA

    Show all 3

    • 4Insider filing for TSHAJan 27
    • 4Insider filing for TSHAJan 27
    • 4Insider filing for TSHAJan 27

    Sukumar Nagendran, reporting

31. ROUTINE144Taysha Gene Therapies, Inc.TSHAJan 23

    7 Form 144 notices

    Sean P. Nolan, planned sale of TSHA shares

    Show all 7

    • 144Planned insider sale of TSHA sharesJan 23
    • 144Planned insider sale of TSHA sharesJan 23
    • 144Planned insider sale of TSHA sharesJan 23
    • 144Planned insider sale of TSHA sharesJan 23
    • 144Planned insider sale of TSHA sharesJan 23
    • 144Planned insider sale of TSHA sharesJan 23
    • 144Planned insider sale of TSHA sharesJan 23

    Sean P. Nolan, reporting

32. ROUTINESCHEDULE 13G/ATaysha Gene Therapies, Inc.TSHAJan 21

    Ownership stake disclosure by BlackRock, Inc. (amended)

    BlackRock, Inc., filed by

33. ROUTINE4Taysha Gene Therapies, Inc.TSHAJan 14

    3 insider filings

    Sukumar Nagendran, insider filing for TSHA

    Show all 3

    • 4Insider filing for TSHAJan 14
    • 4Insider filing for TSHAJan 14
    • 4Insider filing for TSHAJan 14

    Sukumar Nagendran, reporting

Older filings on EDGAR